chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: CSF culture, Dermatitis allergic, Dermatitis contact, Drug administered at inappropriate site, Erythema
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Erythema multiforme, Haematocrit decreased, Haemoglobin decreased, Lumbar puncture abnormal, Neutrophil count increased
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Pharyngeal oedema, Platelet count normal, Pyrexia, Rash, Skin lesion
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Urine analysis, Urticaria, White blood cell count normal
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Erythema multiforme, Rash
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Band neutrophil count increased, Blood alkaline phosphatase increased, Blood bicarbonate normal, Blood chloride normal, Blood creatinine normal
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: CSF culture, Culture urine, Dermatitis contact, Erythema, Erythema multiforme
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Haematocrit decreased, Haemoglobin normal, Lumbar puncture, Neutrophil count increased, Pharyngeal oedema
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Platelet count normal, Pyrexia, Rash, Skin lesion, Urine analysis
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5, DTAP, HEP, HIBV, IPV, PNC, RV1, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5, DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Urticaria, White blood cell count normal
Clinical narrative: This case was reported by a healthcare professional (physician assistant) and described the occurrence of anaphylaxis in a 10-week-old male subject who was vaccinated with Dtap (GlaxoSmithKline), Hepatitis B, ROTARIX, Hib, PREVNAR (non-gsk) and IPV (non-gsk). Concurrent medical conditions included premature birth (infant). On 17 August 2013 the subject received unspecified dose of Dtap (unknown, "leg" (unknown thigh)), unspecified dose of Hepatitis B (unknown), unspecified dose of ROTARIX (oral), unspecified dose of Hib (unknown), unspecified dose of PREVNAR (unknown), unspecified dose of IPV (Non-GSK) (unknown). On 17 August 2013, less than one day after vaccination with Dtap, Hib, Hepatitis B, IPV (Non-GSK), PREVNAR and ROTARIX, the subject experienced anaphylaxis, hive and fever. The subject also developed throat swelling, the reporter stated it was unclear when it started. The subject was hospitalised and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). Immunization series with DTap was delayed. At the time of reporting the events were resolved. The healthcare professional considered the events were probably related to vaccination with Dtap, Hepatitis B, ROTARIX, Hib, PREVNAR and IPV (Non-GSK).
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Burning sensation, Mobility decreased, Pain in extremity
Clinical narrative: 1/10/14 PNEUMOVAX 23 administered at 1030AM. At supper, pt arm hurt. After dinner, she couldn't move her arm - it felt like knives in her arm and it progressed to a "sumo wrestler" sized arm with a hot burning area. She received DECACRON IV and DEPOMEDROL IM.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Dyspnoea, Throat tightness
Clinical narrative: Presents with c/o feeling weak, thought her throat was closing up and had difficulty breathing. 5 hours after ZOSTAVAX vaccine given. Given BENADRYL and transported to hospital for IVF, IVP steroids and discharged home.
Age: 64.0
Sex: F
Vaccine: FLUX
Symptoms: Joint range of motion decreased, Pain, Periarthritis, Swelling
Clinical narrative: After receiving flu vaccine I experienced severe pain, swelling and limited range of motion.
Age: 16.0
Sex: M
Vaccine: HPV4
Symptoms: Immediate post-injection reaction, Loss of consciousness, Nausea, Pallor
Clinical narrative: Gave HPV injection. Patient immediately passed out, had small seizure (10 - 15 seconds), became pale, got nauseous. We laid him down and called in his PCP.
Age: 60.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Axillary pain, Chills, Neck pain, Swelling, Wheezing
Clinical narrative: Chills, wheezing, swell like grapefruit, pain all the way to neck and under arm.
Age: 23.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Immediate post-injection reaction, Injection site swelling, Malaise
Clinical narrative: Injection site swelled immediately and formed a "dime" size bump. Then went down after few minutes. 15 - 20 min later area about 2 inches swollen - didn't "feel well", light headed.
Age: 40.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Hypoaesthesia, Neuralgia, Paraesthesia
Clinical narrative: Numbness and tingling on right hand, all fingers two days after TDAP injection; numbness did not go away after one month.  After 3 weeks, there was increased numbness and symptoms of nerve pain started.  The nerve pain is in the palm of the right hand, there is continued numbness and tingling in all fingers on the right hand.
Age: 26.0
Sex: F
Vaccine: TDAP
Symptoms: VIIth nerve paralysis
Clinical narrative: UNILATERAL FACIAL PALSY ("BELL'S PALSY").
Age: 2.0
Sex: M
Vaccine: DTAPIPV, FLU4, HEPA, IPV
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Patient was given a Kinrix (DTaP/IPV) combination vaccine instead of the Daptacel (DTaP) vaccine.  He was also given a Ipol (Polio) vaccine and Hepatitis A and Influenza vaccines.  So, he received Kinrix off-license and also received a dose of polio vaccine.  He did not have any adverse effects.
Age: 30.0
Sex: F
Vaccine: DTAP, FLU3
Symptoms: Exposure during pregnancy, Musculoskeletal stiffness, Pain
Clinical narrative: I experience extreme pain and shoulder stiffness on my right side that very evening of vaccination. Went to my doctor on 1/9/2014 at 9:30am. My doctor believes I was injured as a result of the vaccination being administrated too high on my right shoulder, causing injury to the bursa. I am pregnant so treatment is restricted. I've been using a sling, taking Tylenol regularly along with icing my right shoulder. Today on 1/13/2014, I called my doctor again for another option since my pain and stiffness has made little improvement.
Age: 14.0
Sex: M
Vaccine: HPV4, VARCEL
Symptoms: Body temperature increased, Chills, Erythema, Injection site erythema, Injection site pruritus
Clinical narrative: On 1/9/14 received call from school RN at 2:00 pm reporting patient complained of right arm itching, where vaccine was given, RN reported that the area was red and raised about the size of a half dollar coin and the patient had a temperature of 99.7 F.  RN also states patient reported having chills. At 4:30 pm on 1/9/14 child came to public health clinic where deputy director and RN's assessed patient who was found to have 5-7 cm area of raised redness, warm to the touch.  Patient referred to Urgent care for assessment and treatment.  Patient went to Urgent care the same day (1/9/14) and was referred to the local ER to have area drained.  Patient was placed on Clindamycin 300 mg 4 x a day and Tylenol with codeine #3 1-2 tabs Q 4-6 hours prn.  Follow-up call to school RN on 1/13/2014 at 10:00 am, School RN reports she assessed patient and reported that right arm area has improved with minimal to no redness and reports the child is taking the antibiotics.
Age: 14.0
Sex: M
Vaccine: HPV4, VARCEL
Symptoms: Injection site swelling, Skin warm, Swelling
Clinical narrative: On 1/9/14 received call from school RN at 2:00 pm reporting patient complained of right arm itching, where vaccine was given, RN reported that the area was red and raised about the size of a half dollar coin and the patient had a temperature of 99.7 F.  RN also states patient reported having chills. At 4:30 pm on 1/9/14 child came to public health clinic where deputy director and RN's assessed patient who was found to have 5-7 cm area of raised redness, warm to the touch.  Patient referred to Urgent care for assessment and treatment.  Patient went to Urgent care the same day (1/9/14) and was referred to the local ER to have area drained.  Patient was placed on Clindamycin 300 mg 4 x a day and Tylenol with codeine #3 1-2 tabs Q 4-6 hours prn.  Follow-up call to school RN on 1/13/2014 at 10:00 am, School RN reports she assessed patient and reported that right arm area has improved with minimal to no redness and reports the child is taking the antibiotics.
Age: 28.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Musculoskeletal pain, Pain, Rotator cuff syndrome
Clinical narrative: Extreme soreness within 1.5 hours after the shot was administered.  I noticed that the administrator gave the vaccine much higher on my left shoulder than I expected or have had before.  The pain began to subside about a week after the initial vaccine, but came back within a couple days.  Extreme pain in the front part of my shoulder, especially when dressing/undressing, turning the wheel of my car, at work (bar tending), putting my seatbelt on.  Anything where the arm crossed my torso made it worse.  I visited my physician and he determined an impingement in my rotator cuff, which could be from the needle hitting the bursa (from being too high).  I have been icing regularly, and applying Voltaren gel 4 times/day for a week (so far).  If the pain continues for a couple more weeks, a cortisone shot is the next course of action.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: At the injection site, there is pain, warmth, swelling, redness, itching.
Age: 0.18
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13, RV5
Symptoms: Haematemesis
Clinical narrative: Patient had one episode of hematemesis.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: Raised rash/red, itchy on (L) arm around administration site.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Colitis microscopic, Colonoscopy abnormal, Diarrhoea
Clinical narrative: Loose stools, diarrhea.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Increased viscosity of nasal secretion, Rhinorrhoea, Sinus congestion, Sneezing
Clinical narrative: Headache, sinus congestion, thick nasal secretions lasting two weeks. Then constant sneezing runny nose. Treated with decongestant Tylenol and Zyrtec.
Age: 24.0
Sex: M
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Fever 103.2.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site warmth, Rash generalised, Sluggishness
Clinical narrative: Red, hot at site on injection, body rash, sluggish feeling.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Insomnia, Pain in extremity
Clinical narrative: Patient presented with a chief complaint of an upper sore arm.  She also complained of insomnia due to the pain on the injection site.
Age: 1.09
Sex: M
Vaccine: DTAPIPV, HEPA, HIBV, MMR, PNC13
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: No adverse reactions occurred but child who was 13 months at the time was given Kinrix.  No reactions were reported.
Age: 50.0
Sex: F
Vaccine: TD
Symptoms: Arthralgia, Headache, Injection site pain, Injection site swelling
Clinical narrative: Swelling and tenderness at the site of injection, diffuse joint aches, headache.
Age: 27.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Ear pain, Fatigue, Headache, Laboratory test
Clinical narrative: Vertigo, ear pain and neck soreness, overall fatigue. Treated for suspected inner ear infection, symptoms improved but vertigo did not resolve. Have since returned with vertigo, blurred vision, myalgias (neck pain, joint pains, ear pain) and headaches.
Age: 27.0
Sex: F
Vaccine: FLUX
Symptoms: Labyrinthitis, Myalgia, Neck pain, Nuclear magnetic resonance imaging, Vertigo
Clinical narrative: Vertigo, ear pain and neck soreness, overall fatigue. Treated for suspected inner ear infection, symptoms improved but vertigo did not resolve. Have since returned with vertigo, blurred vision, myalgias (neck pain, joint pains, ear pain) and headaches.
Age: 27.0
Sex: F
Vaccine: FLUX
Symptoms: Vision blurred
Clinical narrative: Vertigo, ear pain and neck soreness, overall fatigue. Treated for suspected inner ear infection, symptoms improved but vertigo did not resolve. Have since returned with vertigo, blurred vision, myalgias (neck pain, joint pains, ear pain) and headaches.
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Rhinorrhoea
Clinical narrative: Excessive nasal drainage, continuing as of this date.
Age: 41.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Extreme shoulder and arm pain on the side of the injection. Required pain medication.
Age: 49.0
Sex: M
Vaccine: VARCEL
Symptoms: Anaphylactic reaction, Dyspnoea, Full blood count, Hyperhidrosis, Laboratory test
Clinical narrative: Shortness of breath; Erythematous (generalized); Diaphoresis; Face swollen; Anaphylaxis.
Age: 49.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash erythematous, Swelling face
Clinical narrative: Shortness of breath; Erythematous (generalized); Diaphoresis; Face swollen; Anaphylaxis.
Age: 44.0
Sex: M
Vaccine: FLU4
Symptoms: Chest pain, Dyspnoea, Erythema, Feeling hot, Gait disturbance
Clinical narrative: Initial report received from a healthcare professional on 06 January 2014. A 44-year-old patient had received a first dose of FLUZONE QIV (lot number: not reported, route of administration was not reported) in the left deltoid on 15 December 2013. The patient had a medical history of asthma and gluten allergy and the patient had received a flu vaccine in June (year not reported), and had no reaction. On 15 December 2013, few hours after vaccination, the patient became hot and red, had vomiting for several days, nausea, trouble breathing, shortness of breath, knees swelled up and had trouble walking and shaking, chest pain. The patient had similar episode which were unrelated to a vaccine in the past but the past time became blind briefly and the patient had to take prednisone which was diagnosed as allergic reaction. Laboratory investigation and corrective treatments were not reported. The patient had not recovered till the time of this report. Documents held by sender: none.
Age: 44.0
Sex: M
Vaccine: FLU4
Symptoms: Hypersensitivity, Joint swelling, Nausea, Tremor, Vomiting
Clinical narrative: Initial report received from a healthcare professional on 06 January 2014. A 44-year-old patient had received a first dose of FLUZONE QIV (lot number: not reported, route of administration was not reported) in the left deltoid on 15 December 2013. The patient had a medical history of asthma and gluten allergy and the patient had received a flu vaccine in June (year not reported), and had no reaction. On 15 December 2013, few hours after vaccination, the patient became hot and red, had vomiting for several days, nausea, trouble breathing, shortness of breath, knees swelled up and had trouble walking and shaking, chest pain. The patient had similar episode which were unrelated to a vaccine in the past but the past time became blind briefly and the patient had to take prednisone which was diagnosed as allergic reaction. Laboratory investigation and corrective treatments were not reported. The patient had not recovered till the time of this report. Documents held by sender: none.
Age: 1.65
Sex: M
Vaccine: FLU3
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: The patient developed a red, slightly raised rash the morning after the influenza vaccination. Rash was itchy. It was starting to resolve by Friday afternoon.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Mobility decreased
Clinical narrative: The next morning, every joint ached and could hardly move. Shot was received on 11/1/13, patient symptoms developed the morning of 11/2/13.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age and gender. On an unknown date, the patient received "two injections" of ZOSTAVAX (lot #, dose and route not provided). It was unclear as to whether these two injections of ZOSTAVAX were given at the same time or not. No side effects were reported at this time. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to a number of unspecified patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with M-M-R II (dose and lot number were not reported). Concomitant therapy was not reported. From approximately October 2013 through December 2013, the patients may have received M-M-R II whose temperatures were not monitored in a refrigerator. The reporter did not know the temperatures the vaccines were exposed to during this period of time or if any excursions occurred. M-M-R II was not supported due to lack of temperature data. No adverse symptoms were reported. This case is linked to the same source (MARRS# 1401USA005011 and 1401USA005012). Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to a number of unspecified patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with GARDASIL (dose and lot number were not repotted). Concomitant therapy were not reported. From approximately October 2013 through December 2013, the patient may have received GARDASIL whose temperatures were not monitored in a refrigerator. The reporter did not know the temperatures the vaccines were exposed to during this period of time or if any excursions occurred. GARDASIL was not supported due to lack of temperature data. No adverse symptoms were reported. This case is linked to the same source (MARRS# 1401USA004015 and 1401USA005012). Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to a number of unspecified patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with ROTATEQ, oral (dose and lot number were not reported). Concomitant therapy was not reported. From approximately October 2013 through December 2013, the patients may have received ROTATEQ whose temperatures were not monitored in a refrigerator. The reporter did not known the temperatures the vaccines were exposed to during this period of time or if any excursions occurred. ROTATEQ was not supported due to lack of temperature data. No adverse symptoms were reported. This case is linked to the same source (MARRS# 1401USA004015 and 1401USA005011). Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Stomatitis
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 71 year old female patient. In April 2013 the patient was vaccinated with a dose of ZOSTAVAX (lot # J000432, expired date 10-APR-2014)(dosage and route information unspecified). The pharmacist reported that the patient experienced several sores, in her mouth, after received ZOSTAVAX. The patient had experienced several episodes of the mouth sores that "come and go." The patient had seen physician for medical attention. One unspecified physician correlated the sores in the mouth to ZOSTAVAX. The reported did not assess the relationship of the event and ZOSTAVAX. The outcome of the patient was unknown. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV2
Symptoms: Electromyogram, Immunoglobulin therapy, Lumbar puncture, Muscular weakness, Paraesthesia
Clinical narrative: Symptoms: tingling in finger tips, weakness in fingers, hands and arms.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Mobility decreased, Pain
Clinical narrative: Patient was claiming she can't move arm and had shooting pain. She has been going to physical therapy for her arm.
Age: 66.0
Sex: M
Vaccine: FLU3, PPV, VARZOS, PPV, VARZOS, FLU3, PPV, VARZOS
Symptoms: Neuropathy peripheral
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old male patient with hypertension. In January 2013, reported as 'on an unspecified date about 12 months ago', the patient was vaccinated with his first dose of ZOSTAVAX. Lot number, expiry date and route were not reported. On 18-DEC-2013 the patient was vaccinated in the arm with a second dose of ZOSTAVAX (lot number J010447, expiry date 22-APR-2014), subcutaneous. Other suspect therapy included PNEUMOVAX23, which was administered on 18-DEC-2013 in the other arm without problems. Concomitant therapy included unspecified therapy for hypertension. When ZOSTAVAX was administered, the patient winced and was visibly in pain. On 18-DEC-2013, the patient experienced severe pain in entire arm (disability). As from an unknown date in December 2013 the pain was radiating to right side of his face (disability). In December 2013 the patient experienced tingling in the entire arm where ZOSTAVAX was administered (disability) and difficulty sleeping (disability). On an unknown date, the patient visited a physician for the events. On 28-DEC-2013, the patient visited the reporting pharmacist with prescriptions for Tramadol (manufacturer unknown), diazepam (manufacturer unknown) and VALIUM (manufacturer unknown). The outcome of severe pain in entire arm, radiating to right side of his face, tingling in the entire arm where ZOSTAVAX was administered and difficulty sleeping was reported as not recovered/not resolved as of 10-JAN-2014. The patient reported as this point in time that the prescribed medications were not working for his symptoms (not further specified). The patient was scheduled to have an X-ray performed on an unknown date. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: FLU3, PPV, VARZOS, PPV, VARZOS, FLU3, PPV, VARZOS
Symptoms: Facial pain, Injection site reaction, Insomnia, Pain, Pain in extremity
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old male patient with hypertension. In January 2013, reported as 'on an unspecified date about 12 months ago', the patient was vaccinated with his first dose of ZOSTAVAX. Lot number, expiry date and route were not reported. On 18-DEC-2013 the patient was vaccinated in the arm with a second dose of ZOSTAVAX (lot number J010447, expiry date 22-APR-2014), subcutaneous. Other suspect therapy included PNEUMOVAX23, which was administered on 18-DEC-2013 in the other arm without problems. Concomitant therapy included unspecified therapy for hypertension. When ZOSTAVAX was administered, the patient winced and was visibly in pain. On 18-DEC-2013, the patient experienced severe pain in entire arm (disability). As from an unknown date in December 2013 the pain was radiating to right side of his face (disability). In December 2013 the patient experienced tingling in the entire arm where ZOSTAVAX was administered (disability) and difficulty sleeping (disability). On an unknown date, the patient visited a physician for the events. On 28-DEC-2013, the patient visited the reporting pharmacist with prescriptions for Tramadol (manufacturer unknown), diazepam (manufacturer unknown) and VALIUM (manufacturer unknown). The outcome of severe pain in entire arm, radiating to right side of his face, tingling in the entire arm where ZOSTAVAX was administered and difficulty sleeping was reported as not recovered/not resolved as of 10-JAN-2014. The patient reported as this point in time that the prescribed medications were not working for his symptoms (not further specified). The patient was scheduled to have an X-ray performed on an unknown date. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: FLU3, PPV, VARZOS, PPV, VARZOS, FLU3, PPV, VARZOS
Symptoms: Paraesthesia
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 66 year old male patient with hypertension. In January 2013, reported as 'on an unspecified date about 12 months ago', the patient was vaccinated with his first dose of ZOSTAVAX. Lot number, expiry date and route were not reported. On 18-DEC-2013 the patient was vaccinated in the arm with a second dose of ZOSTAVAX (lot number J010447, expiry date 22-APR-2014), subcutaneous. Other suspect therapy included PNEUMOVAX23, which was administered on 18-DEC-2013 in the other arm without problems. Concomitant therapy included unspecified therapy for hypertension. When ZOSTAVAX was administered, the patient winced and was visibly in pain. On 18-DEC-2013, the patient experienced severe pain in entire arm (disability). As from an unknown date in December 2013 the pain was radiating to right side of his face (disability). In December 2013 the patient experienced tingling in the entire arm where ZOSTAVAX was administered (disability) and difficulty sleeping (disability). On an unknown date, the patient visited a physician for the events. On 28-DEC-2013, the patient visited the reporting pharmacist with prescriptions for Tramadol (manufacturer unknown), diazepam (manufacturer unknown) and VALIUM (manufacturer unknown). The outcome of severe pain in entire arm, radiating to right side of his face, tingling in the entire arm where ZOSTAVAX was administered and difficulty sleeping was reported as not recovered/not resolved as of 10-JAN-2014. The patient reported as this point in time that the prescribed medications were not working for his symptoms (not further specified). The patient was scheduled to have an X-ray performed on an unknown date. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Body temperature increased, Feeling abnormal, Headache, Herpes zoster, Hyperacusis
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 60 year old female patient. None pertinent medical history reported. No known allergies were reported. On 08-JAN-2014, the patient was vaccinated with ZOSTAVAX lot # J007854, expiration date: 28-SEP-2014, 0.65 ml, subcutaneously in the left arm. Concomitant therapies included metoprolol. On 09-JAN-2014, the patient developed a headache in the morning. On 10-JAN-2014, the patient's left arm was red, warm to touch, swollen from the elbow to shoulder and there were blisters at the injection site of the ZOSTAVAX vaccination. The patient also did not feel good, had body aches, still had a headache, was noise and light sensitive and had a fever of 102F. The patient sought medical attention by going to the emergency room later on 10-JAN-2014. The emergency room physician called the patient's physician office and informed to the nurse that the blisters at the injection site were zoster like blisters. Patient used cold compresses as treatment for the adverse events. Lab studies were not performed. The outcome of left arm was red, warm to touch, swollen from the elbow to shoulder, blisters at the injection site were zoster like blisters, did not feel good, had body aches, headache, noise and light sensitive and had a fever of 102F was reported as not recovered. Causality was not reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles, Injection site warmth
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 60 year old female patient. None pertinent medical history reported. No known allergies were reported. On 08-JAN-2014, the patient was vaccinated with ZOSTAVAX lot # J007854, expiration date: 28-SEP-2014, 0.65 ml, subcutaneously in the left arm. Concomitant therapies included metoprolol. On 09-JAN-2014, the patient developed a headache in the morning. On 10-JAN-2014, the patient's left arm was red, warm to touch, swollen from the elbow to shoulder and there were blisters at the injection site of the ZOSTAVAX vaccination. The patient also did not feel good, had body aches, still had a headache, was noise and light sensitive and had a fever of 102F. The patient sought medical attention by going to the emergency room later on 10-JAN-2014. The emergency room physician called the patient's physician office and informed to the nurse that the blisters at the injection site were zoster like blisters. Patient used cold compresses as treatment for the adverse events. Lab studies were not performed. The outcome of left arm was red, warm to touch, swollen from the elbow to shoulder, blisters at the injection site were zoster like blisters, did not feel good, had body aches, headache, noise and light sensitive and had a fever of 102F was reported as not recovered. Causality was not reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain, Photophobia
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 60 year old female patient. None pertinent medical history reported. No known allergies were reported. On 08-JAN-2014, the patient was vaccinated with ZOSTAVAX lot # J007854, expiration date: 28-SEP-2014, 0.65 ml, subcutaneously in the left arm. Concomitant therapies included metoprolol. On 09-JAN-2014, the patient developed a headache in the morning. On 10-JAN-2014, the patient's left arm was red, warm to touch, swollen from the elbow to shoulder and there were blisters at the injection site of the ZOSTAVAX vaccination. The patient also did not feel good, had body aches, still had a headache, was noise and light sensitive and had a fever of 102F. The patient sought medical attention by going to the emergency room later on 10-JAN-2014. The emergency room physician called the patient's physician office and informed to the nurse that the blisters at the injection site were zoster like blisters. Patient used cold compresses as treatment for the adverse events. Lab studies were not performed. The outcome of left arm was red, warm to touch, swollen from the elbow to shoulder, blisters at the injection site were zoster like blisters, did not feel good, had body aches, headache, noise and light sensitive and had a fever of 102F was reported as not recovered. Causality was not reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Feeling abnormal, Headache, Hyperacusis, Injection site swelling
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 60 year old female patient. None pertinent medical history reported. No known allergies were reported. On 08-JAN-2014, the patient was vaccinated with ZOSTAVAX lot # J007854, expiration date: 28-SEP-2014, 0.65 ml, subcutaneously in the left arm. Concomitant therapies included metoprolol. On 09-JAN-2014, the patient developed a headache in the morning. On 10-JAN-2014, the patient's left arm was red, warm to touch, swollen from the elbow to shoulder and there were blisters at the injection site of the ZOSTAVAX vaccination. The patient also did not feel good, had body aches, still had a headache, was noise and light sensitive and had a fever of 102F. The patient sought medical attention by going to the emergency room later on 10-JAN-2014. The emergency room physician called the patient's physician office and informed to the nurse that the blisters at the injection site were zoster like blisters. Patient used cold compresses as treatment for the adverse events. Lab studies were not performed. The outcome of left arm was red, warm to touch, swollen from the elbow to shoulder, blisters at the injection site were zoster like blisters, did not feel good, had body aches, headache, noise and light sensitive and had a fever of 102F was reported as not recovered. Causality was not reported. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site vesicles, Pain, Photophobia, Pyrexia, Skin warm
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 60 year old female patient. None pertinent medical history reported. No known allergies were reported. On 08-JAN-2014, the patient was vaccinated with ZOSTAVAX lot # J007854, expiration date: 28-SEP-2014, 0.65 ml, subcutaneously in the left arm. Concomitant therapies included metoprolol. On 09-JAN-2014, the patient developed a headache in the morning. On 10-JAN-2014, the patient's left arm was red, warm to touch, swollen from the elbow to shoulder and there were blisters at the injection site of the ZOSTAVAX vaccination. The patient also did not feel good, had body aches, still had a headache, was noise and light sensitive and had a fever of 102F. The patient sought medical attention by going to the emergency room later on 10-JAN-2014. The emergency room physician called the patient's physician office and informed to the nurse that the blisters at the injection site were zoster like blisters. Patient used cold compresses as treatment for the adverse events. Lab studies were not performed. The outcome of left arm was red, warm to touch, swollen from the elbow to shoulder, blisters at the injection site were zoster like blisters, did not feel good, had body aches, headache, noise and light sensitive and had a fever of 102F was reported as not recovered. Causality was not reported. Additional information has been requested.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Balance disorder, Dizziness, Dysphagia, Dyspnoea, Headache
Clinical narrative: Hives on arms, hives in mouth, extreme itching, headache, hives on chest, trouble swallowing, trouble breathing, dizziness, loss of balance.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives on arms, hives in mouth, extreme itching, headache, hives on chest, trouble swallowing, trouble breathing, dizziness, loss of balance.
Age: 12.0
Sex: F
Vaccine: VARCEL
Symptoms: Macule, Pruritus, Rash pustular, Varicella post vaccine
Clinical narrative: Breakthrough chicken pox.  20 pustules/macules on abdomen.  Itchy.